About 10 results found for searched term "S1R agonist 1" (0.123 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41882 | hNTS1R agonist-1 | Neurotensin Receptor |
| hNTS1R agonist-1 is a BBB permeable hNTS1R full agonist (Ki: 6.9 nM) . | ||
| M42697 | S1R agonist 1 hydrochloride | Sigma Receptor |
| S1R agonist 1 hydrochloride is a selective S1R agonist with Kis of 0.93 nM and 72 nM for S1R and S2R, respectively. | ||
| M42699 | S1R agonist 1 | Sigma Receptor |
| S1R agonist 1 is a selective S1R agonist with Kis of 0.93 nM and 72 nM for S1R and S2R, respectively. | ||
| M28096 | S1RA hydrochloride | Sigma Receptor |
| E-52862 hydrochloride | ||
| S1RA (E-52862) hydrochloride is an orally active and selective sigma-1 receptor (σ1R) antagonist with a Ki value of 17 nM. S1RA hydrochloride shows good selectivity against σ2R (Ki >1000 nM). S1RA hydrochloride is a human 5-HT2B receptor antagonist with an IC50 value of 4.7 μM. S1RA hydrochloride inhibits neuropathic pain and activity-induced spinal sensitization. | ||
| M42698 | S1R agonist 2 hydrochloride | Sigma Receptor |
| S1R agonist 2 hydrochloride is a selective S1R agonist with Kis of 1.1 nM and 88 nM for S1R and S2R, respectively. | ||
| M42700 | S1R agonist 2 | Sigma Receptor |
| S1R agonist 2 is a selective S1R agonist with Kis of 1.1 nM and 88 nM for S1R and S2R, respectively. | ||
| M42701 | AD186 | Sigma Receptor |
| AD186 is a potent and selective S1R agonist with Kis of 2.7, 27 nM for S1R and S2R, respectively. | ||
| M42702 | AB21 oxalate | Sigma Receptor |
| AB21 oxalate is a potent and selective S1R antagonist with Kis of 13, 102 nM for S1R and S2R. | ||
| M42703 | AB21 | Sigma Receptor |
| AB21 is a potent and selective S1R antagonist with Kis of 13, 102 nM for S1R and S2R. | ||
| M53103 | TAK-683 | Others |
| TAK-683 is a potent full KISS1 receptor (KISS1R) agonist (IC50=170 pM) with improved metabolic stability. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
